|
US5908825A
(en)
*
|
1997-01-09 |
1999-06-01 |
University Of Maryland At Baltimore |
Dosage composition for nasal delivery and method of use of the same
|
|
US6458925B1
(en)
*
|
1998-08-03 |
2002-10-01 |
University Of Maryland, Baltimore |
Peptide antagonists of zonulin and methods for use of the same
|
|
CN1221249C
(zh)
|
1998-08-19 |
2005-10-05 |
斯凯伊药品加拿大公司 |
普鲁泊福的可注射水分散体
|
|
KR100615442B1
(ko)
*
|
1998-09-14 |
2006-08-25 |
유니버시티 오브 메릴랜드, 볼티모어 |
항원-특이적 방식으로 림프구 증식을 저해하기 위한 조트또는 조눌린의 사용방법
|
|
US6733762B1
(en)
|
1998-09-14 |
2004-05-11 |
University Of Maryland, Baltimore |
Method of using Zot to inhibit lymphocyte proliferation in an antigen-specific manner
|
|
EP1221975B1
(en)
|
1999-10-04 |
2006-12-06 |
Nektar Therapeutics Al, Corporation |
Polymer stabilized neuropeptides
|
|
US7026294B2
(en)
*
|
2000-05-19 |
2006-04-11 |
University Of Maryland |
Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes
|
|
US7034036B2
(en)
*
|
2000-10-30 |
2006-04-25 |
Pain Therapeutics, Inc. |
Inhibitors of ABC drug transporters at the blood-brain barrier
|
|
EP1384468A1
(de)
*
|
2002-07-25 |
2004-01-28 |
Cognis France S.A. |
Verfahren zum Schutz und zur Modulation von Tight Junctions
|
|
EP1384469A1
(de)
*
|
2002-07-25 |
2004-01-28 |
Cognis France S.A. |
Verfahren zum Schutz und zur Modulation von Tight Junctions
|
|
CA2531491A1
(en)
*
|
2003-07-15 |
2005-02-03 |
University Of Maryland, Baltimore |
Agonist polypeptide of receptor for zot and zonulin
|
|
US20080038843A1
(en)
*
|
2006-08-11 |
2008-02-14 |
University Of Maryland - Baltimore |
Method of diagnosing celiac disease
|
|
TW200637573A
(en)
*
|
2005-01-14 |
2006-11-01 |
Univ Maryland |
Peptide for delivery of mucosal vaccines
|
|
TW200716159A
(en)
*
|
2005-06-09 |
2007-05-01 |
Univ Maryland |
Method of use of antagonists of zonulin to prevent the loss of or to regenerate pancreatic cells
|
|
AR060103A1
(es)
*
|
2006-02-09 |
2008-05-28 |
Alba Therapeutics Corp |
Formulaciones para un efector de uniones apretadas
|
|
US20070239520A1
(en)
*
|
2006-03-31 |
2007-10-11 |
Devin Collins |
Motivational apparatus and method of motivation
|
|
WO2008043107A2
(en)
*
|
2006-10-06 |
2008-04-10 |
Alba Therapeutics Corporation |
Use of tight junction antagonists to treat inflammatory bowel disease
|
|
US8034776B2
(en)
*
|
2006-10-26 |
2011-10-11 |
Alba Therapeutics Corporation |
Materials and methods for the treatment of celiac disease
|
|
US20100144646A1
(en)
*
|
2006-11-03 |
2010-06-10 |
Blake Paterson |
Method of diagnosing and treating asthma
|
|
WO2009023311A2
(en)
*
|
2007-05-07 |
2009-02-19 |
Alba Therapeutics Corporation |
Transcutaneous delivery of therapeutic agents
|
|
WO2009006246A1
(en)
*
|
2007-06-29 |
2009-01-08 |
Alea Therapeutics Corp. |
Use of tight junction antagonists in the treatment of acute long injury and acute respiratory distress syndrome
|
|
WO2009015382A2
(en)
|
2007-07-26 |
2009-01-29 |
Alba Therapeutics Corporation |
Novel peptides that enhance tight junction permeability
|
|
KR102236462B1
(ko)
|
2012-03-19 |
2021-04-08 |
시다라 세라퓨틱스, 인코포레이티드 |
에키노칸딘 계열의 화합물에 대한 투여 용법
|
|
JP6760657B2
(ja)
*
|
2015-05-26 |
2020-09-23 |
国立大学法人東海国立大学機構 |
タイトジャンクションの緩和剤、該緩和剤を含む薬剤吸収補助剤、及び該緩和剤を含む医薬組成物
|
|
JP2020507626A
(ja)
|
2017-02-10 |
2020-03-12 |
イノベイト バイオファーマシューティカルズ インコーポレイテッド |
腸上皮の透過性と関連する疾患を治療する組成物及び方法
|
|
US11608359B2
(en)
|
2018-02-23 |
2023-03-21 |
9 Meters Biopharma, Inc. |
Compounds and methods for treating tight junction permeabtility
|